shutterstock_1950591379_nitpicker
12 October 2023Marisa Woutersen

Linklaters hires partner to ‘meet growing client demand’

New addition brings multi-jurisdiction experience in life sciences and healthcare industries | Significant growth in patent litigation due to complex life sciences disputes and telecom and technology litigation.

Linklaters has added Katie Coltart as partner to its IP team.

Coltart makes the move from Kirkland & Ellis where she has been a partner since 2018, having previously worked at Allen & Overy.

She has experience in cross-border IP litigation in a range of different sectors including healthcare and life sciences, telecoms and technology.

Commenting on the appointment, Julia Schönbohm, partner and global head of TMT/IP at Linklaters, explained that the recent growth in patent litigation was due to the complex nature of life sciences disputes, and the increase in the number of telecom and technology litigation cases.

“With Katie’s impressive experience in complex, multi-jurisdictional IP disputes, her expertise complements the growth of our IP litigation capabilities and meets growing client demand,” said Schönbohm.

Coltart said: “The strength of the firm’s global platform is a very attractive draw as clients look for solutions to increasingly complex, multi-jurisdictional disputes.

“Linklaters has a fantastic client base and strong track record for patent disputes, and I am looking forward to joining the team and building on that success,” she added.

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
5 October 2023   Both attorneys have ‘exceptional experience’ in life sciences and previously practised at Dechert.
Americas
11 July 2023   John Rearick is the latest addition to the firm to strengthen its life sciences practice.
Americas
1 February 2024   Firm adds to its New York office with the appointment of ANDA expert as a partner in litigation group | Represented clients such as Gilead, Sanofi-Aventis, and Bristol-Myers Squibb in high-stakes cases.

More on this story

Americas
11 July 2023   John Rearick is the latest addition to the firm to strengthen its life sciences practice.
Biotechnology
5 October 2023   Both attorneys have ‘exceptional experience’ in life sciences and previously practised at Dechert.
Americas
1 February 2024   Firm adds to its New York office with the appointment of ANDA expert as a partner in litigation group | Represented clients such as Gilead, Sanofi-Aventis, and Bristol-Myers Squibb in high-stakes cases.

More on this story

Americas
11 July 2023   John Rearick is the latest addition to the firm to strengthen its life sciences practice.
Biotechnology
5 October 2023   Both attorneys have ‘exceptional experience’ in life sciences and previously practised at Dechert.
Americas
1 February 2024   Firm adds to its New York office with the appointment of ANDA expert as a partner in litigation group | Represented clients such as Gilead, Sanofi-Aventis, and Bristol-Myers Squibb in high-stakes cases.